|
|
Thyroid Cancer Patients with Postoperative 131I Treatment Method of Radiation Protection |
SHU Jin-xia |
The Second Affiliated Hospital of Soochow University, Suzhou 215004 China |
|
|
Abstract Objective To evaluate the postoperative patients with thyroid cancer 131I treatment method of radiation protection.Methods Randomly selected from November 2014 to January 2016, 125 patients with thyroid cancer, all patients with thyroid cancer surgery, to 131I treatment with radiation protection. Adverse reactions occurred in patients with statistics, comparing patients quality of life before and after radiation protection.Results In 125 patients after 131I treatment for a period of time after the incidence of adverse reactions was 7.20% (9/125), including loss of appetite, nausea, 5 cases (4.00%), much dream, insomnia, 3 cases (2.40%), and parotid gland swelling with mild pain in 1 case (0.80%), after symptomatic treatment, the above adverse reactions are effectively ease or disappear. Protection after the patients' physiological functions, for physical pain and so on, the survival quality score is higher than before protection, statistically significant differences (P<0.05).Conclusion In patients with thyroid carcinoma postoperative treatment during 131I to offer effective protective measures can reduce the incidence of adverse reactions and improve the quality of survival, which should be actively explored, summarized and applied clinically.
|
Received: 17 December 2016
|
|
|
|
|
[1] 郑隽.甲状腺癌术后患者131I治疗期间辐射防护的管理[J].护士进修杂志,2012,27(8):685-686. [2] 栾兆生,周雯,李艳玲,等.核素131I治疗分化型甲状腺癌辐射并发症的防治[J].中国辐射卫生,2013,22(6):762-764. [3] 中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797. [4] 池晓华,刘峰,李贵平,等.距离在甲状腺癌患者131I治疗中的屏蔽作用[J].南方医科大学学报,2014,34(2):286-288. [5] 许丹,许彤,陆艳红,等.甲状腺癌术后口服碘131治疗后的护理[J].中国医药指南,2013,11(2):640-641. [6] Maruoka,Y.,Abe,K.,Baba,S. et al.Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma[J].Annals of nuclear medicine,2013,27(10):873-879. [7] 钱明理,杜学亮,傅宏亮,等.分化型甲状腺癌术后131I清甲治疗对甲状旁腺功能的影响[J].放射免疫学杂志,2012,25(4):369-372. [8] 陈春燕,韩春彩,李军,等.使用131I治疗甲状腺癌的工作场所的辐射防护设计[J].中国辐射卫生,2014,23(3):247-249. [9] 刘志平.护理干预在儿童青少年甲状腺癌术后131碘治疗中的应用[J].当代护士(专科版),2012,18(7):93-95. [10] 陆涤宇,周俊,夏亮,等.分化型甲状腺癌术后131I治疗1周后辐射相对安全距离的分析[J].中国临床医生,2014,42(10):28-30. [11] Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid:A comparison of ablation success with different activities of radioiodine (I-131)[J].Annals of nuclear medicine,2012,26(9):744-751. [12] 范素云,柴丽,王艳波,等.甲状腺癌患者131I治疗期间的辐射防护及护理管理[J].中华核医学与分子影像杂志,2016,36(3):263-264. |
|
|
|